Clinically, it has been found that the use of IFN-γ to treat viral infections such as hepatitis C can cause symptoms such as fever, diarrhea, headache, chills, nausea, muscle pain and/or fatigue. The gene discussed is IFNG; the disease is viral infectious disease.